Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aprindine.

P Danilo

    American Heart Journal
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Aprindine is an effective long-acting antiarrhythmic drug for ventricular and atrial arrhythmias, including Wolff-Parkinson-White syndrome. Careful dosing minimizes side effects, making it a potentially valuable addition to existing treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term electrophysiological effects of regional cardiac sympathetic denervation of the neonatal dog.

    Cardiovascular research·2001
    Same author

    Altering ventricular activation remodels gap junction distribution in canine heart.

    Journal of cardiovascular electrophysiology·2001
    Same author

    Impact of sex and gonadal steroids on prolongation of ventricular repolarization and arrhythmias induced by I(K)-blocking drugs.

    Circulation·2001
    Same author

    Interactions between antiarrhythmic drugs and cardiac memory.

    Cardiovascular research·2001
    Same author

    Cardiac memory in canine atrium : identification and implications.

    Circulation·2001
    Same author

    beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.

    Cardiovascular research·2000
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Ventricular arrhythmias require effective long-term treatment options.
    • Current antiarrhythmic therapies have limitations and potential side effects.

    Purpose of the Study:

    • To evaluate the efficacy and safety of aprindine as an antiarrhythmic agent.
    • To determine aprindine's utility in treating various cardiac arrhythmias.

    Main Methods:

    • Administration of aprindine via oral and intravenous routes.
    • Assessment of treatment effectiveness in patients with ventricular and atrial arrhythmias.
    • Monitoring for potential side effects, including cholestatic jaundice and agranulocytosis.

    Main Results:

    • Aprindine demonstrated effectiveness in treating ventricular arrhythmias of diverse origins.

    Related Experiment Videos

  • The drug showed potential utility in managing Wolff-Parkinson-White syndrome.
  • Aprindine also exhibited efficacy, to a lesser extent, in atrial arrhythmias.
  • Side effects were manageable through careful dose titration.

    • Conclusions:

    • Aprindine is a promising long-acting antiarrhythmic agent for ventricular arrhythmias.
    • Its effectiveness in Wolff-Parkinson-White syndrome warrants further consideration.
    • With appropriate dosing, aprindine can be a valuable therapeutic option, provided serious side effects remain infrequent.